Intellia Therapeutics, Inc. (NTLA)
NASDAQ·Healthcare·Biotechnology
$11.20
-1.01%
Mkt Cap $1.75B
Analyst Ratings
Buy
5
Hold
3
Sell
1
Price Target (58 analysts)
$21.64
Range $8.00 – $49.00
Implied Upside
+93.2%
Consensus $21.64 vs current $11.20
NASDAQ·Healthcare·Biotechnology
$11.20
-1.01%
Mkt Cap $1.75B
Buy
5
Hold
3
Sell
1
Price Target (58 analysts)
$21.64
Range $8.00 – $49.00
+93.2%
Consensus $21.64 vs current $11.20